Location: BOSTON, MA
CIK: 0001816307 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 14, 2026
Total Value ($000): $979,812 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SPDR SERIES TRUST | 825,000 | $105,377 | 10.8% | — | — | PUT | 78464A950 |
| ZBIO | ZENAS BIOPHARMA INC | 1,135,935 | $22,208 | 2.3% | $21.89 | 0.0% | COM | 98937L105 |
| SRRK | SCHOLAR ROCK HLDG CORP | 339,613 | $16,695 | 1.7% | $45.48 | 0.0% | COM | 80706P103 |
| ALKS | ALKERMES PLC | 460,314 | $16,277 | 1.7% | $32.34 | 0.0% | SHS | G01767105 |
| IRON | DISC MEDICINE INC | 196,028 | $12,534 | 1.3% | $74.04 | 0.0% | COM | 254604101 |
| HLXC | HELIX ACQUISITION CORP III | 1,208,986 | $12,283 | 1.3% | $10.16 | — | USD CL A ORD SHS | G4444S107 |
| XENE | XENON PHARMACEUTICALS INC | 197,759 | $11,500 | 1.2% | $41.98 | 0.0% | COM | 98420N105 |
| IMVT | IMMUNOVANT INC | 414,236 | $10,290 | 1.1% | $26.26 | 0.0% | COM | 45258J102 |
| SVRA | SAVARA INC | 1,430,982 | $7,813 | 0.8% | $5.69 | 0.0% | COM | 805111101 |
| — | SYNDAX PHARMACEUTICALS INC | 320,000 | $7,475 | 0.8% | — | — | CALL | 87164F905 |
| ORKA | ORUKA THERAPEUTICS INC | 150,908 | $7,402 | 0.8% | $32.45 | 0.0% | COM | 687604108 |
| — | CELCUITY INC | 54,500 | $6,221 | 0.6% | — | — | CALL | 15102K900 |
| CYTK | CYTOKINETICS INC | 71,203 | $4,693 | 0.5% | $64.44 | 0.0% | COM NEW | 23282W605 |
| CLYM | CLIMB BIO INC | 684,908 | $4,692 | 0.5% | $5.00 | 0.0% | COM | 28658R106 |
| ZURA | ZURA BIO LTD | 560,651 | $3,336 | 0.3% | $5.88 | 0.0% | CLASS A ORD SHS | G9TY5A101 |
| CAMP | CAMP4 THERAPEUTICS CORP | 653,594 | $2,882 | 0.3% | $4.67 | 0.0% | COM | 13463J101 |
| ANNX | ANNEXON INC | 496,461 | $2,750 | 0.3% | $5.75 | 0.0% | COM | 03589W102 |
| CBIO | CRESCENT BIOPHARMA INC. | 130,500 | $2,397 | 0.2% | $11.06 | 0.0% | COM | G2545C104 |
| MNPR | MONOPAR THERAPEUTICS INC | 43,488 | $2,383 | 0.2% | $62.79 | 0.0% | COM NEW | 61023L207 |
| OVID | OVID THERAPEUTICS INC | 1,000,000 | $2,220 | 0.2% | $1.60 | 0.0% | COM | 690469101 |
| CMPS | COMPASS PATHWAYS PLC | 300,000 | $1,659 | 0.2% | $5.53 | — | SPONSORED ADS | 20451W101 |
| NMRA | NEUMORA THERAPEUTICS INC. | 818,156 | $1,595 | 0.2% | $2.46 | 0.0% | COM | 640979100 |
| REPL | REPLIMUNE GROUP INC | 171,936 | $1,315 | 0.1% | $7.81 | 0.0% | COM | 76029N106 |
| GENB | GENERATE BIOMEDICINES INC | 100,000 | $1,250 | 0.1% | $12.50 | — | COM SHS | 370920100 |
| — | COMPASS THERAPEUTICS INC | 172,400 | $912 | 0.1% | — | — | CALL | 20454B904 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ERAS | ERASCA INC | 1,851,812 (+40.5%) | $29,962 (+511.3%) | 3.1% | $4.46 | +124.9% | COM | 29479A108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 2,876,407 (+18.5%) | $57,902 (+47.7%) | 5.9% | $12.52 | +23.7% | COM | 483497103 |
| ASND | ASCENDIS PHARMA A/S | 124,658 (+153.2%) | $28,513 (+171.6%) | 2.9% | $196.77 | — | SPONSORED ADR | 04351P101 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 2,002,040 (+94.5%) | $32,934 (+104.1%) | 3.4% | $14.13 | +46.2% | COM | 61225M102 |
| IMNM | IMMUNOME INC | 1,850,278 (+64.3%) | $40,466 (+67.3%) | 4.1% | $19.71 | +17.0% | COM | 45257U108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 306,000 (+125.1%) | $26,613 (+82.9%) | 2.7% | $74.67 | +37.7% | COM | 76243J105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 888,987 (+38.3%) | $20,767 (+53.7%) | 2.1% | $18.33 | +13.2% | COM | 87164F105 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 466,345 (+1.8%) | $18,523 (+61.6%) | 1.9% | $24.95 | — | SPONSORED ADS | 152309100 |
| COGT | COGENT BIOSCIENCES INC | 1,314,189 (+5.5%) | $50,583 (+14.4%) | 5.2% | $18.51 | +101.9% | COM | 19240Q201 |
| NUVL | NUVALENT INC | 354,914 (+14.0%) | $36,361 (+16.1%) | 3.7% | $77.35 | +34.0% | COM | 670703107 |
| FULC | FULCRUM THERAPEUTICS INC | 419,949 (+6.4%) | $3,221 (-27.8%) | 0.3% | $10.19 | +1.8% | COM | 359616109 |
| ABEO | ABEONA THERAPEUTICS INC | 648,942 (+3.4%) | $2,907 (-12.1%) | 0.3% | $5.72 | -9.7% | COM NEW | 00289Y206 |
| EWTX | EDGEWISE THERAPEUTICS INC | 42,615 (+1.3%) | $1,342 (+28.6%) | 0.1% | $20.18 | +39.6% | COM | 28036F105 |
| GH | GUARDANT HEALTH INC | 98,514 (+7.2%) | $9,100 (-3.1%) | 0.9% | $90.66 | +18.5% | COM | 40131M109 |
| IBIO | IBIO INC | 226,000 (+113.2%) | $429 (+109.9%) | 0.0% | $1.87 | +23.8% | COM NEW | 451033708 |
| CERS | CERUS CORP | 3,176,547 (+12.9%) | $5,781 (-0.3%) | 0.6% | $3.16 | -25.8% | COM | 157085101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VRDN | VIRIDIAN THERAPEUTICS INC | 348,569 | $10,847 | 1.1% | $20.44 | +50.9% | — | 92790C104 |
| PFE | PFIZER INC | 419,134 | $10,436 | 1.1% | $25.03 | +4.6% | — | 717081103 |
| AVTX | AVALO THERAPEUTICS INC | 524,436 | $9,524 | 1.0% | $8.60 | +80.2% | — | 05338F306 |
| GOSS | GOSSAMER BIO INC | 2,135,722 | $6,621 | 0.7% | $1.12 | +100.9% | — | 38341P102 |
| LXEO | LEXEO THERAPEUTICS INC | 617,608 | $6,133 | 0.6% | $4.84 | +55.8% | — | 52886X107 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 506,242 | $6,115 | 0.6% | $9.41 | +48.6% | — | 03237H101 |
| SLNO | SOLENO THERAPEUTICS INC | 117,485 | $5,440 | 0.6% | $54.83 | -24.1% | — | 834203309 |
| OLMA | OLEMA PHARMACEUTICALS INC | 206,280 | $5,157 | 0.5% | $6.00 | +323.9% | — | 68062P106 |
| — | KALVISTA PHARMACEUTICALS INC | 290,600 | $4,693 | 0.5% | — | — | CALL | 483497903 |
| MLYS | MINERALYS THERAPEUTICS INC | 94,983 | $3,447 | 0.4% | $16.01 | +95.8% | — | 603170101 |
| RLAY | RELAY THERAPEUTICS INC | 398,167 | $3,368 | 0.3% | $7.14 | +16.3% | — | 75943R102 |
| QURE | UNIQURE NV | 126,047 | $3,016 | 0.3% | $15.14 | +55.6% | — | N90064101 |
| TARS | TARSUS PHARMACEUTICALS INC | 36,124 | $2,958 | 0.3% | $74.67 | -6.6% | — | 87650L103 |
| KYMR | KYMERA THERAPEUTICS INC | 34,589 | $2,691 | 0.3% | $67.53 | +14.9% | — | 501575104 |
| — | ULTRAGENYX PHARMACEUTICAL IN | 110,000 | $2,530 | 0.3% | — | — | CALL | 90400D908 |
| CTMX | CYTOMX THERAPEUTICS INC | 385,974 | $1,644 | 0.2% | $3.80 | +37.6% | — | 23284F105 |
| XFOR | X4 PHARMACEUTICALS INC | 357,387 | $1,430 | 0.1% | $3.63 | +0.1% | — | 98420X202 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 100,000 | $750 | 0.1% | $10.14 | -15.5% | — | 35104E100 |
| RAPP | RAPPORT THERAPEUTICS INC | 9,659 | $293 | 0.0% | $17.84 | +56.0% | — | 75383L102 |
| PALI | PALISADE BIO INC | 102,108 | $240 | 0.0% | $1.92 | -7.2% | — | 696389402 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DNTH | DIANTHUS THERAPEUTICS INC | 654,746 (-12.7%) | $54,946 (+77.7%) | 5.6% | $26.43 | +80.0% | COM | 252828108 |
| ABVX | ABIVAX SA | 302,530 (-28.3%) | $33,687 (-40.8%) | 3.4% | $84.90 | — | SPONSORED ADS | 00370M103 |
| GUTS | FRACTYL HEALTH INC | 1,701,625 (-82.7%) | $779 (-96.4%) | 0.1% | $1.40 | -14.2% | COM | 35168W103 |
| URGN | UROGEN PHARMA LTD | 1,503,045 (-13.6%) | $27,025 (-33.6%) | 2.8% | $13.27 | +57.0% | COM | M96088105 |
| VCYT | VERACYTE INC | 179,700 (-49.7%) | $5,788 (-61.5%) | 0.6% | $34.23 | +14.9% | COM | 92337F107 |
| KOD | KODIAK SCIENCES INC | 991,930 (-3.0%) | $37,812 (+32.2%) | 3.9% | $7.38 | +244.7% | COM | 50015M109 |
| — | UNIQURE NV | 500,000 (-30.6%) | $8,175 (-52.6%) | 0.8% | — | — | CALL | N90064901 |
| INSM | INSMED INC | 35,850 (-49.7%) | $5,862 (-52.7%) | 0.6% | $56.86 | +179.7% | COM PAR $.01 | 457669307 |
| ORIC | ORIC PHARMACEUTICALS INC | 1,100,010 (-1.5%) | $13,937 (+52.6%) | 1.4% | $6.76 | +59.4% | COM | 68622P109 |
| BIIB | BIOGEN INC | 50,967 (-32.4%) | $9,344 (-29.6%) | 1.0% | $135.17 | +35.6% | COM | 09062X103 |
| AARD | AARDVARK THERAPEUTICS INC | 33,684 (-88.9%) | $127 (-96.8%) | 0.0% | $10.73 | +26.5% | COM | 002942100 |
| CGON | CG ONCOLOGY INC | 166,349 (-53.9%) | $11,259 (-24.9%) | 1.1% | $24.86 | +110.9% | COM | 156944100 |
| CELC | CELCUITY INC | 357,903 (-4.6%) | $40,851 (+9.2%) | 4.2% | $72.23 | +48.8% | COM | 15102K100 |
| BNTC | BENITEC BIOPHARMA INC | 717,725 (-1.9%) | $7,644 (-22.4%) | 0.8% | $13.20 | -10.8% | COM NEW | 08205P209 |
| CGEN | COMPUGEN LTD | 3,315,845 (-4.7%) | $7,063 (+32.7%) | 0.7% | $1.61 | +14.1% | ORD | M25722105 |
| TELA | TELA BIO INC | 2,259,312 (-14.7%) | $1,401 (-55.2%) | 0.1% | $4.46 | -79.3% | COM | 872381108 |
| PCVX | VAXCYTE INC | 144,981 (-2.6%) | $8,425 (+22.7%) | 0.9% | $32.81 | +60.8% | COM | 92243G108 |
| PRAX | PRAXIS PRECISION MEDICINES I | 71,552 (-13.2%) | $23,053 (-5.2%) | 2.4% | $100.25 | +211.0% | COM NEW | 74006W207 |
| CCCC | C4 THERAPEUTICS INC | 1,911,785 (-4.1%) | $5,028 (+32.0%) | 0.5% | $2.40 | -13.0% | COM STK | 12529R107 |
| CMPX | COMPASS THERAPEUTICS INC | 859,049 (-18.3%) | $4,544 (-19.5%) | 0.5% | $2.86 | +109.9% | COM | 20454B104 |
| ELUT | ELUTIA INC | 2,498,020 (-9.2%) | $2,623 (+37.6%) | 0.3% | $3.14 | -70.3% | CL A COM | 05479K106 |
| TRVI | TREVI THERAPEUTICS INC | 511,127 (-5.6%) | $6,098 (-10.0%) | 0.6% | $3.55 | +208.1% | COM | 89532M101 |
| SRZN | SURROZEN INC | 144,255 (-8.3%) | $4,202 (+18.2%) | 0.4% | $16.18 | +37.4% | COM NEW | 86889P208 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 178,378 (-6.6%) | $5,658 (+9.0%) | 0.6% | $27.17 | -6.5% | COM NEW | 15117B202 |
| CTNM | CONTINEUM THERAPEUTICS INC | 301,729 (-1.9%) | $3,941 (+12.1%) | 0.4% | $9.60 | +39.1% | CL A | 21217B100 |
| ADGM | ADAGIO MED HLDGS INC | 251,972 (-51.1%) | $290 (-45.9%) | 0.0% | $1.19 | -17.3% | COM | 00534B100 |
| SION | SIONNA THERAPEUTICS INC | 39,417 (-4.9%) | $1,580 (-7.4%) | 0.2% | $15.09 | +160.1% | COM | 829401108 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SYRE | SPYRE THERAPEUTICS INC | 186,618 | $9,413 | 1.0% | $26.13 | +32.2% | COM NEW | 00773J202 |
| — | FULCRUM THERAPEUTICS INC | 391,900 | $3,006 | 0.3% | — | — | CALL | 359616909 |
| NXTC | NEXTCURE INC | 176,057 | $1,880 | 0.2% | $10.36 | +21.4% | COM NEW | 65343E207 |
| RADX | RADIOPHARM THERANOSTICS LTD | 187,406 | $806 | 0.1% | $4.49 | — | SPONSORED ADS | 75041J101 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 104,828 | $2 | 0.0% | $0.11 | — | *W EXP 09/02/202 | 77313F114 |